521 related articles for article (PubMed ID: 20469967)
1. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
3. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
[TBL] [Abstract][Full Text] [Related]
7. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
[TBL] [Abstract][Full Text] [Related]
8. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
9. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
10. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A
Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
[TBL] [Abstract][Full Text] [Related]
12. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
13. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
14. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
[TBL] [Abstract][Full Text] [Related]
16. Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.
Fitzpatrick LR; Small JS; Doblhofer R; Ammendola A
J Pharmacol Exp Ther; 2012 Sep; 342(3):850-60. PubMed ID: 22691298
[TBL] [Abstract][Full Text] [Related]
17. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of glycyrrhizic acid by rectal treatment on a TNBS-induced rat colitis model.
Liu Y; Xiang J; Liu M; Wang S; Lee RJ; Ding H
J Pharm Pharmacol; 2011 Mar; 63(3):439-46. PubMed ID: 21749393
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
